Literature DB >> 20443994

Evidence-based recommendations to assess psoriasis severity: systematic literature review and expert opinion of a panel of dermatologists.

C Paul1, P-A Gourraud, V Bronsard, S Prey, E Puzenat, S Aractingi, F Aubin, M Bagot, B Cribier, P Joly, D Jullien, M Le Maitre, M-A Richard-Lallemand, J-P Ortonne.   

Abstract

BACKGROUND: Severity of psoriasis appears to be multidimensional and its assessment in everyday clinical practice requires a complex holistic approach.
OBJECTIVES: To develop evidence-based recommendations to assess severity of plaque-type psoriasis in adult patients in everyday clinical practice.
METHODS: A scientific committee (10 members identified on the basis of their expertise in psoriasis) using Delphi methodology selected eight questions in three domains: severity, health-related quality of life (HR-QoL) and comorbidities. Three systematic literature reviews (one per domain) of all studies published between January 1980 and June 2009 were performed based on Pub-Med, Cochrane and Embase database. Selected articles were systematically reviewed and evidence appraised according to the Oxford Levels of Evidence. On June 2009, a group of 44 French dermatologists both hospital and office based participated in a meeting including three separate rounds of discussions, plenary sessions, and modified Delphi technique votes. Recommendations for clinical practice based on systematic review and clinical experience were formulated by the group. Subsequently, agreements among the participants regarding these recommendations as well as potential impact on clinical practice were evaluated.
RESULTS: A total of 10 642 references were identified, of which 154 articles were analysed. Ten key recommendations on the assessment of psoriasis severity were formulated: three recommendations relating to severity assessment, three recommendations relating to HR-QoL (including the use of the Dermatology Life Quality Index [DLQI] in clinical practice) and four recommendations relating to comorbidities (including systematic screening for peripheral or axial inflammatory joint damage, regardless of psoriasis severity).
CONCLUSIONS: Ten recommendations to assess the severity of plaque-type psoriasis in adult patients in daily practice were developed. The recommendations are based on systematic appraisal of available evidence. They were developed and supported by a panel of dermatologists, which enhances their validity and practical relevance.

Entities:  

Mesh:

Year:  2010        PMID: 20443994     DOI: 10.1111/j.1468-3083.2009.03561.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  8 in total

1.  Disease severity and therapy as predictors of cardiovascular risk in psoriasis: a population-based cohort study.

Authors:  H Maradit-Kremers; M Icen; F C Ernste; R A Dierkhising; M T McEvoy
Journal:  J Eur Acad Dermatol Venereol       Date:  2012-03       Impact factor: 6.166

2.  Evaluating practice patterns for managing moderate to severe plaque psoriasis: role of the family physician.

Authors:  Yves Poulin; Norman Wasel; Daphne Chan; Geula Bernstein; Robin Andrew; Elisa Fraquelli; Kim Papp
Journal:  Can Fam Physician       Date:  2012-07       Impact factor: 3.275

3.  Impact of Bariatric Surgery on Moderate to Severe Psoriasis: A Retrospective Nationwide Registry Study.

Authors:  Marta Laskowski; Linus Schiöler; Johan Ottosson; Marcus Schmitt-Egenolf; Ann-Marie Wennberg; Torsten Olbers; Kjell Torén; Helena Gustafsson
Journal:  Acta Derm Venereol       Date:  2021-06-30       Impact factor: 3.875

4.  Investigation of Immunovascular Polymorphisms and Intersections in Psoriasis.

Authors:  Buket Er Urganci; Ibrahim Acikbas; F Rezzan Er
Journal:  Indian J Dermatol       Date:  2019 May-Jun       Impact factor: 1.494

5.  Short-Term Correlation of the Psoriasis Area Severity Index, the Nail Psoriasis Area Severity Index, and the Dermatology Life Quality Index, before and after Treatment, in Patients with Skin and Nail Psoriasis.

Authors:  Christos Prevezas; Alexander C Katoulis; Evangelia Papadavid; Pantelis Panagakis; Dimitrios Rigopoulos
Journal:  Skin Appendage Disord       Date:  2019-05-21

6.  Measuring disease activity in psoriatic arthritis.

Authors:  Priscilla C H Wong; Ying-Ying Leung; Edmund K Li; Lai-Shan Tam
Journal:  Int J Rheumatol       Date:  2012-12-25

7.  Evaluation of Erythroid Disturbance and Thiol-Disulphide Homeostasis in Patients with Psoriasis.

Authors:  Suzan Demir Pektas; Gokhan Pektas; Kursad Tosun; Gursoy Dogan; Salim Neselioglu; Ozcan Erel
Journal:  Biomed Res Int       Date:  2018-06-05       Impact factor: 3.411

8.  An Analysis of IL-10, IL-17A, IL-17RA, IL-23A and IL-23R Expression and Their Correlation with Clinical Course in Patients with Psoriasis.

Authors:  Magdalena Kutwin; Monika Migdalska-Sęk; Ewa Brzeziańska-Lasota; Piotr Zelga; Anna Woźniacka
Journal:  J Clin Med       Date:  2021-12-13       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.